Role of COX-2 in cough reflex sensitivity to inhaled capsaicin in patients with sinobronchial syndrome

Cough

Volumn 6, Issue 1, 2010, Pages

  Ishiura, Yoshihisa ^a   Fujimura, Masaki ^b   Yamamoto, Hiroki ^a   Ohkura, Noriyuki ^b   Myou, Shigeharu ^b  

^a Toyama City Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955294026     PISSN: None     EISSN: 17459974     Source Type: Journal    
DOI: 10.1186/1745-9974-6-7     Document Type: Article

References (24)

1. Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T. Diffuse panbronchiolitis; a disease of the transitional zone of the lung. Chest 1983, 83:63-69. 10.1378/chest.83.1.63, 6848335.
2. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998, 157:1829-1832.
3. Ishiura Y, Fujimura M, Saito M, Shibata K, Nomura M, Nakatsumi Y, Matsuda T. Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome. Respir Med 1995, 89:677-684. 10.1016/0954-6111(95)90135-3, 8570882.
4. Kurashima K, Fujimura M, Hoyano Y, Takemura K, Matsuda T. Effect of thromboxane A2 synthetase inhibitor, OKY-046, on sputum in chronic bronchitis and diffuse panbronchiolitis. Eur Respir J 1995, 8:1705-1711. 10.1183/09031936.95.08101705, 8586126.
5. Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis 1992, 145:548-552.
6. Samuelsson B. An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes. Drugs 1987, 33:2-9. 10.2165/00003495-198700331-00003, 3036460.
7. Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 1996, 62:167-215. full_text, 8781269.
8. Belvisi MG, Saunders MA, Haddad E, Hirst SJ, Yacoub MH, Barnes PJ, Mitchell JA. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol 1997, 120:910-916. 10.1038/sj.bjp.0700963, 1564529, 9138698.
9. Fujimura M, Kamio Y, Kasahara K, Bando T, Hashimoto T, Matsuda T. Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J 1995, 8:1499-1505.
10. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004, 18:790-804. 10.1096/fj.03-0645rev, 15117884.
11. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999, 96:7563-7568. 10.1073/pnas.96.13.7563, 22126, 10377455.
12. Suzaki H, Ichimura K, Kudoh S, Sugiyama Y, Symposium MH. Sinobronchial syndrome and its related subjects: clinical observation in sinobronchial syndrome from a viewpoint of otorhinolaryngology. J Jap Bronchoesophagol Soc 1987, 38:181-186.
13. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Effects of methacholine-induced bronchoconstriction and procaterol-induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax 1992, 47:441-445. 10.1136/thx.47.6.441, 463809, 1386691.
14. Bresalier R, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA. Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352:1092-1103. 10.1056/NEJMoa050493, 15713943.
15. Psaty BM, Furberg CD. COX-2 inhibitors - Lessons in drug safety. N Engl J Med 2005, 352:1133-1135. 10.1056/NEJMe058042, 15713946.
16. McEwan JR, Choudry NB, Fuller RW. The effect of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Exp Ther 1991, 255:161-164.
17. Kadota I, Sakito O, Kohno S, Sawa H, Murae H, Oda H, Kawakami K, Fukushima K, Hiratani K, Hara K. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993, 147:153-159.
18. Ogawa H, Fujimura M, Amaike S, Matsumoto Y, Matsuda T. Effect of clarithromycin on cough receptor sensitivity to capsaicin in patients with sinobronchial syndrome. J Jap Bronchology 1996, 18:543-547.
19. Ishiura Y, Fujimura M, Yamamori C, Nobata K, Myou S, Kurashima K, Takegoshi T. Thromboxane antagonism and cough in chronic bronchitis. Ann Med 2003, 35:135-139. 10.1080/07853890310010032, 12795341.
20. Ishiura Y, Fujimura M, Yamamoto H, Ishiguro T, Ohkura N, Myou S. COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. J Investig Allergol Clin Immunol 2009, 19:370-374.
21. Kamei J, Matsunawa Y, Saitoh A. Antitussive effect of NS-398, a selective cyclooxygenase-2 inhibitor, in guinea pigs. Eur J Pharmacol 2004, 497:233-239. 10.1016/j.ejphar.2004.06.045, 15306209.
22. Bresalier R, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA. Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352:1092-1103. 10.1056/NEJMoa050493, 15713943.
23. Psaty BM, Furberg CD. COX-2 inhibitors - Lessons in drug safety. N Engl J Med 2005, 352:1133-1135. 10.1056/NEJMe058042, 15713946.
24. Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Safety 2006, 29:621-632. 10.2165/00002018-200629070-00007, 16808554.